Search
Now showing items 1-1 of 1
STUDIES OF AXL, HER2, AND PDGFRβ RECEPTOR TYROSINE KINASES IN MUTANT KRAS-DRIVEN PANCREATIC CANCER IN VITRO
This project proposes to demonstrate the overexpression of the selected tyrosine kinase receptor,
RTK, (AXL, HER2, and PDGFRβ) and their participation in oncogenic KRAS driven pancreatic cancer in
vitro. The experimental ...